2023-07-012024-06-302024-06-30false12042791HEALTH CONSULTANCY GROUP LIMITED2025-03-25falseiso4217:GBPxbrli:pure120427912023-07-01120427912024-06-30120427912023-07-012024-06-30120427912022-07-01120427912023-06-30120427912022-07-012023-06-3012042791bus:SmallEntities2023-07-012024-06-3012042791bus:AuditExempt-NoAccountantsReport2023-07-012024-06-3012042791bus:FullAccounts2023-07-012024-06-3012042791bus:PrivateLimitedCompanyLtd2023-07-012024-06-3012042791core:WithinOneYear2024-06-3012042791core:AfterOneYear2024-06-3012042791core:WithinOneYear2023-06-3012042791core:AfterOneYear2023-06-301204279112023-07-012024-06-3012042791core:ShareCapital2024-06-3012042791core:SharePremium2024-06-3012042791core:RevaluationReserve2024-06-3012042791core:OtherReservesSubtotal2024-06-3012042791core:RetainedEarningsAccumulatedLosses2024-06-3012042791core:ShareCapital2023-06-3012042791core:SharePremium2023-06-3012042791core:RevaluationReserve2023-06-3012042791core:OtherReservesSubtotal2023-06-3012042791core:RetainedEarningsAccumulatedLosses2023-06-3012042791core:LandBuildings2024-06-3012042791core:PlantMachinery2024-06-3012042791core:Vehicles2024-06-3012042791core:FurnitureFittings2024-06-3012042791core:OfficeEquipment2024-06-3012042791core:NetGoodwill2024-06-3012042791core:IntangibleAssetsOtherThanGoodwill2024-06-3012042791core:ListedExchangeTraded2024-06-3012042791core:UnlistedNon-exchangeTraded2024-06-3012042791core:LandBuildings2023-06-3012042791core:PlantMachinery2023-06-3012042791core:Vehicles2023-06-3012042791core:FurnitureFittings2023-06-3012042791core:OfficeEquipment2023-06-3012042791core:NetGoodwill2023-06-3012042791core:IntangibleAssetsOtherThanGoodwill2023-06-3012042791core:ListedExchangeTraded2023-06-3012042791core:UnlistedNon-exchangeTraded2023-06-3012042791core:LandBuildings2023-07-012024-06-3012042791core:PlantMachinery2023-07-012024-06-3012042791core:Vehicles2023-07-012024-06-3012042791core:FurnitureFittings2023-07-012024-06-3012042791core:OfficeEquipment2023-07-012024-06-3012042791core:NetGoodwill2023-07-012024-06-3012042791core:IntangibleAssetsOtherThanGoodwill2023-07-012024-06-3012042791core:ListedExchangeTraded2023-07-012024-06-3012042791core:UnlistedNon-exchangeTraded2023-07-012024-06-3012042791core:MoreThanFiveYears2023-07-012024-06-3012042791core:Non-currentFinancialInstruments2024-06-3012042791core:Non-currentFinancialInstruments2023-06-3012042791dpl:CostSales2023-07-012024-06-3012042791dpl:DistributionCosts2023-07-012024-06-3012042791core:LandBuildings2023-07-012024-06-3012042791core:PlantMachinery2023-07-012024-06-3012042791core:Vehicles2023-07-012024-06-3012042791core:FurnitureFittings2023-07-012024-06-3012042791core:OfficeEquipment2023-07-012024-06-3012042791dpl:AdministrativeExpenses2023-07-012024-06-3012042791core:NetGoodwill2023-07-012024-06-3012042791core:IntangibleAssetsOtherThanGoodwill2023-07-012024-06-3012042791dpl:GroupUndertakings2023-07-012024-06-3012042791dpl:ParticipatingInterests2023-07-012024-06-3012042791dpl:GroupUndertakingscore:ListedExchangeTraded2023-07-012024-06-3012042791core:ListedExchangeTraded2023-07-012024-06-3012042791dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-07-012024-06-3012042791core:UnlistedNon-exchangeTraded2023-07-012024-06-3012042791dpl:CostSales2022-07-012023-06-3012042791dpl:DistributionCosts2022-07-012023-06-3012042791core:LandBuildings2022-07-012023-06-3012042791core:PlantMachinery2022-07-012023-06-3012042791core:Vehicles2022-07-012023-06-3012042791core:FurnitureFittings2022-07-012023-06-3012042791core:OfficeEquipment2022-07-012023-06-3012042791dpl:AdministrativeExpenses2022-07-012023-06-3012042791core:NetGoodwill2022-07-012023-06-3012042791core:IntangibleAssetsOtherThanGoodwill2022-07-012023-06-3012042791dpl:GroupUndertakings2022-07-012023-06-3012042791dpl:ParticipatingInterests2022-07-012023-06-3012042791dpl:GroupUndertakingscore:ListedExchangeTraded2022-07-012023-06-3012042791core:ListedExchangeTraded2022-07-012023-06-3012042791dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-07-012023-06-3012042791core:UnlistedNon-exchangeTraded2022-07-012023-06-3012042791core:NetGoodwill2024-06-3012042791core:IntangibleAssetsOtherThanGoodwill2024-06-3012042791core:LandBuildings2024-06-3012042791core:PlantMachinery2024-06-3012042791core:Vehicles2024-06-3012042791core:FurnitureFittings2024-06-3012042791core:OfficeEquipment2024-06-3012042791core:AfterOneYear2024-06-3012042791core:WithinOneYear2024-06-3012042791core:ListedExchangeTraded2024-06-3012042791core:UnlistedNon-exchangeTraded2024-06-3012042791core:ShareCapital2024-06-3012042791core:SharePremium2024-06-3012042791core:RevaluationReserve2024-06-3012042791core:OtherReservesSubtotal2024-06-3012042791core:RetainedEarningsAccumulatedLosses2024-06-3012042791core:NetGoodwill2023-06-3012042791core:IntangibleAssetsOtherThanGoodwill2023-06-3012042791core:LandBuildings2023-06-3012042791core:PlantMachinery2023-06-3012042791core:Vehicles2023-06-3012042791core:FurnitureFittings2023-06-3012042791core:OfficeEquipment2023-06-3012042791core:AfterOneYear2023-06-3012042791core:WithinOneYear2023-06-3012042791core:ListedExchangeTraded2023-06-3012042791core:UnlistedNon-exchangeTraded2023-06-3012042791core:ShareCapital2023-06-3012042791core:SharePremium2023-06-3012042791core:RevaluationReserve2023-06-3012042791core:OtherReservesSubtotal2023-06-3012042791core:RetainedEarningsAccumulatedLosses2023-06-3012042791core:NetGoodwill2022-07-0112042791core:IntangibleAssetsOtherThanGoodwill2022-07-0112042791core:LandBuildings2022-07-0112042791core:PlantMachinery2022-07-0112042791core:Vehicles2022-07-0112042791core:FurnitureFittings2022-07-0112042791core:OfficeEquipment2022-07-0112042791core:AfterOneYear2022-07-0112042791core:WithinOneYear2022-07-0112042791core:ListedExchangeTraded2022-07-0112042791core:UnlistedNon-exchangeTraded2022-07-0112042791core:ShareCapital2022-07-0112042791core:SharePremium2022-07-0112042791core:RevaluationReserve2022-07-0112042791core:OtherReservesSubtotal2022-07-0112042791core:RetainedEarningsAccumulatedLosses2022-07-0112042791core:AfterOneYear2023-07-012024-06-3012042791core:WithinOneYear2023-07-012024-06-3012042791core:Non-currentFinancialInstrumentscore:CostValuation2023-07-012024-06-3012042791core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-07-012024-06-3012042791core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-07-012024-06-3012042791core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-07-012024-06-3012042791core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-07-012024-06-3012042791core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-07-012024-06-3012042791core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-07-012024-06-3012042791core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-07-012024-06-3012042791core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-07-012024-06-3012042791core:Non-currentFinancialInstrumentscore:CostValuation2024-06-3012042791core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-06-3012042791core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-06-3012042791core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-06-3012042791core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-06-3012042791core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-06-3012042791core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-06-3012042791core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-06-3012042791core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-06-3012042791core:Non-currentFinancialInstrumentscore:CostValuation2023-06-3012042791core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-06-3012042791core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-06-3012042791core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-06-3012042791core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-06-3012042791core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-06-3012042791core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-06-3012042791core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-06-3012042791core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-06-3012042791bus:Director12023-07-012024-06-30

HEALTH CONSULTANCY GROUP LIMITED

(formerly PRISM PT LIMITED)

Registered Number
12042791
(England and Wales)

Unaudited Financial Statements for the Year ended
30 June 2024

HEALTH CONSULTANCY GROUP LIMITED
Company Information
for the year from 1 July 2023 to 30 June 2024

Director

DRAKE, Christopher

Registered Address

253 253 Monton Road
Eccles
Manchester
M30 9PS

Registered Number

12042791 (England and Wales)
HEALTH CONSULTANCY GROUP LIMITED
Balance Sheet as at
30 June 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets32,8391,436
2,8391,436
Current assets
Debtors43,0994,634
Cash at bank and on hand6,9783,684
10,0778,318
Creditors amounts falling due within one year5(5,848)(1,850)
Net current assets (liabilities)4,2296,468
Total assets less current liabilities7,0687,904
Creditors amounts falling due after one year6(6,574)(7,685)
Net assets494219
Capital and reserves
Called up share capital11
Profit and loss account493218
Shareholders' funds494219
The financial statements were approved and authorised for issue by the Director on 25 March 2025, and are signed on its behalf by:
DRAKE, Christopher
Director
Registered Company No. 12042791
HEALTH CONSULTANCY GROUP LIMITED
Notes to the Financial Statements
for the year ended 30 June 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. These critical accounting judgements and estimations are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The critical judgements made by management that have a significant effect on the amounts recognised in the financial statements are described below.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees

20242023
Average number of employees during the year11
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 July 231,9481,948
Additions1,8491,849
At 30 June 243,7973,797
Depreciation and impairment
At 01 July 23512512
Charge for year446446
At 30 June 24958958
Net book value
At 30 June 242,8392,839
At 30 June 231,4361,436
4.Debtors: amounts due within one year

2024

2023

££
Other debtors3,0994,634
Total3,0994,634
5.Creditors: amounts due within one year

2024

2023

££
Taxation and social security5,8481,850
Total5,8481,850
6.Creditors: amounts due after one year

2024

2023

££
Bank borrowings and overdrafts6,5747,685
Total6,5747,685